Engineering the Gut Microbiome: Emerging Genome-Editing Strategies and Therapeutic Applications.

Area of Science:

• Microbiome Engineering
• Synthetic Biology
• Genomic Medicine

Background:

• The gut microbiome significantly impacts host health, with dysbiosis linked to various diseases.
• Current interventions like probiotics and fecal microbiota transplantation (FMT) lack precision and show variable efficacy.
• Limitations include inability to regulate specific strains/genes and interindividual variability in FMT outcomes.

Purpose of the Study:

• To review advancements in genome editing for gut microbiome engineering.
• To explore novel delivery systems and design strategies for targeted microbiome manipulation.
• To discuss applications in metabolic disorders, IBD, cancer immunotherapy, and neuropsychiatric conditions.

Main Methods:

• Utilizing Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR-associated (Cas) systems and base editors for targeted genetic modification of gut bacteria.
• Developing sophisticated delivery systems for engineered microbes.
• Examining strategies for optimizing gut microbial community architecture.

Main Results:

• Genome editing enables precise functional manipulation of gut commensals and community structures.
• Engineered microbial strategies show potential for disease treatment, diagnostics, and immune modulation.
• Applications span metabolic disorders, inflammatory bowel disease (IBD), cancer immunotherapy, and neuropsychiatric conditions.

Conclusions:

• Gut microbiome engineering holds substantial promise for precision therapeutics.
• Addressing technical bottlenecks and biosafety concerns is crucial for clinical translation.
• Future directions include in situ editing, AI-driven design, and personalized microbiome engineering.